Christer Nilsson

9PUBLICATIONS
63CO-AUTHORS
Gene and molecular therapyHaematologyHaematological tumoursMedical molecular engineering of nucleic acids and proteinsRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 23, 2026
Patient-tailored azacitidine, venetoclax and gilteritinib triplet therapy appear to improve tolerability while preserving encouraging clinical outcomes in FLT3-mutated relapsed/refractory AML.

|Nov 11, 2025
Stable clonal contribution of lineage-restricted stem cells to human hematopoiesis.

Tetsuichi Yoshizato, Christer Nilsson, Francesca Grasso

|Sep 27, 2025
Addition of hydroxyurea (hydroxycarbamide) enhances the efficacy of fludarabine/cytarabine-based salvage regimens against acute myeloid leukaemia.

Ingrid Lilienthal, Sijia Tao, Christer Nilsson

|Aug 23, 2025
MALNC: a new mutant NPM1/IDH2R140 and PML-RARA-associated lncRNA with impact on AML cell proliferation, maturation and drug response.

Elisabetta Cozzi, Anne Neddermeyer, Xiangfu Zhong

|Apr 19, 2024
Efficacy of ruxolitinib in the treatment of relapsed/refractory large granular lymphocytic leukaemia.

Tony Marchand, Cédric Pastoret, Gandhi Damaj

|Dec 01, 2023
Clinical and immunological features in ACKR1/DARC-associated neutropenia.

Jan Palmblad, Ebba Sohlberg, Christer C Nilsson

Pageof 2

Frequent Collaborators

2 joint publications

Jan Palmblad

2 joint publications

Sten Eirik W Jacobsen

2 joint publications

Stefan Deneberg

2 joint publications

Eva Hellström-Lindberg